Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 189

The DOI matches its Crossref record.

Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients

Open access
Li, Wen, Yu, Chun-Ping, Xia, Jin-tang, Zhang, Ling, Weng, Gui-Xiang, Zheng, Hai-qing, Kong, Qing-li, Hu, Li-juan, Zeng, Mu-Sheng, Zeng, Yi-xin, Li, Mengfeng, Li, Jun, Song, Li-Bing · 2009 · Clinical Cancer Research

Abstract

Purpose: The present study was to investigate the clinical significance of sphingosine kinase 1 (SPHK1), an oncoenzyme, in the development and progression of gastric cancer. Experimental Design: mRNA and protein levels of SPHK1 expression in normal gastric epithelial cells, gastric cancer cell lines, and paired gastric cancer lesions and the adjacent noncancerous tissues were examined using reverse transcription-PCR and Western blotting. Immunohistochemistry was employed to analyze SPHK1 expression in 175 clinicopathologically characterized gastric cancer cases. Statistical analyses were applied to derive prognostic and diagnostic associations. Results: Levels of SPHK1 mRNA and protein were higher in gastric cancer cell lines than in normal gastric epithelial cells. SPHK1 protein level was up-regulated in gastric cancer lesions compared with that in the paired adjacent noncancerous tissues. Gastric cancer tissues from 115 of 175 (65.7%) patients revealed high level of SPHK1 protein expression in contrast to the undetectable or marginally detectable expression of SPHK1 in the adjacent noncancerous gastric tissues. Significantly different expression levels of SPHK1 were found in patients at different clinical stages (P = 0.003), T classification (P = 0.035), and M classification (P = 0.020). Patients with higher SPHK1 expression had shorter overall survival time, whereas those with lower SPHK1 expression survived longer. Further multivariate analysis suggested that SPHK1 up-regulation was an independent prognostic indicator for the disease. Conclusions: SPHK1 protein could be a useful marker for the prognosis of gastric cancer. Further study on the potential use of SPHK1 as a therapeutic target is also warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-08-1158

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 189

Metadata

Authors
Li, W., Yu, C.-P., Xia, J.-T., Zhang, L., Weng, G.-X., Zheng, H.-Q., Kong, Q.-L., Hu, L.-J., Zeng, M.-S., Zeng, Y.-X., Li, M., Li, J., & Song, L.-B.
Venue
Clinical Cancer Research
Published
2009-02-15
Volume
15
Issue
4
Pages
1393-1399
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2052788204
Cited by
189
References
0
FWCI
5.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-08-1158
The paper
Li, W., Yu, C.-P., Xia, J.-T., Zhang, L., Weng, G.-X., Zheng, H.-Q., Kong, Q.-L., Hu, L.-J., Zeng, M.-S., Zeng, Y.-X., Li, M., Li, J., & Song, L.-B. (2009). Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-08-1158

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.